A Survey on Psychosomatic Health Status of Chinese Population
Launched by YONGGUI YUAN · Dec 1, 2023
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the psychosomatic health status of people in China. Psychosomatic health refers to how our mental and emotional well-being can affect our physical health. The researchers want to gather information about how various psychological factors impact people’s overall well-being. The study will involve a survey that participants can complete online.
To be eligible for this study, participants need to be at least 18 years old and able to complete the survey independently. Unfortunately, individuals with severe physical illnesses or cognitive impairments will not be able to participate. If you choose to take part, you'll read an informed consent form online, which explains the study and what’s expected of you, and then you can share your experiences and thoughts through the survey. This research aims to better understand the relationship between mental and physical health, which could help improve health strategies in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years old and above;
- • Able to complete the scale independently;
- • Subjects read informed consent through online questionnaires and agreed to cooperate with relevant assessments.
- Exclusion Criteria:
- • Individuals with severe physical disease;
- • Individuals with cognitive impairment;
- • Individuals who cannot finish the online survay independently.
About Yonggui Yuan
Yonggui Yuan is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapeutic solutions, the organization operates at the intersection of scientific discovery and patient care. Yonggui Yuan collaborates with leading researchers and healthcare institutions to design and conduct rigorous clinical trials that adhere to the highest ethical and regulatory standards. Their mission is to bring promising treatments to market, ultimately improving health outcomes and enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Yonggui Yuan, Prof.
Study Chair
Zhongda Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported